Literature DB >> 15029460

Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence.

Shohei Yamashina, Jun-ichi Yamazaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15029460     DOI： 10.1007/s00259-004-1493-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  12 in total

1.  Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity.

Authors:  J Y Choi; K H Lee; K P Hong; B T Kim; J D Seo; W R Lee; S H Lee
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

2.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

3.  Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.

Authors:  P Merlet; H Valette; J L Dubois-Randé; D Moyse; D Duboc; P Dove; M H Bourguignon; C Benvenuti; A M Duval; D Agostini
Journal:  J Nucl Med       Date:  1992-04       Impact factor: 10.057

4.  [The results of questionnaire on quantitative assessment of 123I-metaiodobenzylguanidine myocardial scintigraphy in heart failure].

Authors:  T Nishimura; Y Sugishita; Y Sasaki
Journal:  Kaku Igaku       Date:  1997-12

5.  Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

6.  Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.

Authors:  Shu Kasama; Takuji Toyama; Hisao Kumakura; Yoshiaki Takayama; Shuichi Ichikawa; Tadashi Suzuki; Masahiko Kurabayashi
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

7.  Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments--comparison with neurohumoral factors.

Authors:  Toshiki Matsui; Takayoshi Tsutamoto; Keiko Maeda; Junya Kusukawa; Masashiko Kinoshita
Journal:  Circ J       Date:  2002-06       Impact factor: 2.993

8.  Relation of cardiac sympathetic innervation to proinflammatory cytokine levels in patients with heart failure secondary to idiopathic dilated cardiomyopathy.

Authors:  Fragiskos I Parthenakis; Alexandros Patrianakos; Vasilis Prassopoulos; Evangelos Papadimitriou; Dragana Nikitovic; Nikos S Karkavitsas; Panos E Vardas
Journal:  Am J Cardiol       Date:  2003-05-15       Impact factor: 2.778

9.  Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.

Authors:  Hisanori Shinohara; Nobuo Fukuda; Takeshi Soeki; Koichi Sakabe; Yukiko Onose; Yoshiyuki Tamura
Journal:  Heart Vessels       Date:  2002-12       Impact factor: 2.037

10.  Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy.

Authors:  Myron C Gerson; Nancy McGuire; Lynne E Wagoner
Journal:  J Card Fail       Date:  2003-10       Impact factor: 5.712
View more
  11 in total

1.  Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.

Authors:  Kenichi Nakajima; Koichi Okuda; Shinro Matsuo; Mitsuhiro Yoshita; Junichi Taki; Masahito Yamada; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

2.  Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study.

Authors:  Hein J Verberne; Christel Feenstra; W Matthijs de Jong; G Aernout Somsen; Berthe L F van Eck-Smit; Ellinor Busemann Sokole
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-18       Impact factor: 9.236

3.  Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Authors:  Futoshi Anan; Hidetoshi Yonemochi; Takayuki Masaki; Naohiko Takahashi; Mikiko Nakagawa; Nobuoki Eshima; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-04       Impact factor: 9.236

4.  Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.

Authors:  Koichi Okuda; Kenichi Nakajima; Tetsuo Hosoya; Takehiro Ishikawa; Takahiro Konishi; Kosuke Matsubara; Shinro Matsuo; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2010-11-23       Impact factor: 5.952

5.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

6.  Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy.

Authors:  Silvana A D'Orio Nishioka; Martino Martinelli Filho; Simone C Soares Brandão; Maria Clementina Giorgi; Marcelo L C Vieira; Roberto Costa; Wilson Mathias; José Cláudio Meneghetti
Journal:  J Nucl Cardiol       Date:  2007-10-18       Impact factor: 5.952

7.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

8.  Role of interleukin-6 levels in cardiovascular autonomic dysfunction in type 2 diabetic patients.

Authors:  Tetsuji Shinohara; Naohiko Takahashi; Kunio Yufu; Futoshi Anan; Tetsuya Kakuma; Masahide Hara; Mikiko Nakagawa; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-01       Impact factor: 9.236

Review 9.  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function.

Authors:  Kenichi Nakajima
Journal:  Ann Nucl Med       Date:  2010-01-29       Impact factor: 2.668

10.  Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Authors:  Futoshi Anan; Takayuki Masaki; Hidetoshi Yonemochi; Naohiko Takahashi; Mikiko Nakagawa; Nobuoki Eshima; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-06       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.